---
aliases:
  - Molecular target of drug action
---

# Molecular target of drug action

- Xenobiotic: substances that not normally present / produced
- Drug: Substances w/ Biological Effect
	- Drug action: Mechanism that drug produce response
		- Modify physiological effect (existing pathway)
		- Cannot create new pathway
- Drug Targets
	- Specific
		- Receptors
			- Extracellular
			- Intracellular
		- Other Targets
			- Ligands
			- Proteins
			- Nucleic Acids
			- Cell Components
	- Non-Specific
		- Physico-chemical properties
- Drug Intake
	- Oral (Per os; PO)
	- Injection
		- Intravenous (IV)
		- Intramuscular (IM)
		- Subcutaneous (Sc)
		- Specific Injection
			- Intravitreal
			- Intra-articular
			- Intrathecal
	- Inhalation
	- Rectal
	- Topical

## Specific Drug Target

- Receptors: Protein that bind w/ specific (endogenous) ligand
	- Extracellular
		- G Protein-Coupled Receptor (G<sub>s</sub> / G<sub>i</sub> / G<sub>q</sub> / PAR) \*
			- G<sub>s</sub> → Activate Adenylate Cyclase → Increase cAMP
			- G<sub>i</sub> → Inhibit Adenylate Cyclase → Decrease cAMP
				- Open $\ce{K+}$ channel → Hyperpolarization
			- G<sub>q</sub> → Activate phospholipase C → Increase IP<sub>3</sub> + DAG
			- PAR (Protease-activated receptor)
			- Ligands
				- Neurotransmitters
				- Autacoids (Autocoids)
				- Nucleotides
				- Peptide Hormone (Hydrophilic)
				- Plasma Protein (PAR)
					- Thrombin receptor
		- Ligand-gated ion channel (Cation / Anion) \*
			- Ligands
				- Neurotransmitter
					- Glutamate → Cation Channel → Action Potential
					- GABA → Anion Channel → Hyperpolarization
					- Acetylcholine → Cation Channel → Action Potential
				- Nucleotides
					- Purinergic Receptor e.g. P2X receptors
		- Enzyme-linked receptor (RTK / GC-linked)
			- RTK (Receptor Tyrosine Kinase)
				- Intrinsic Tyrosine Kinase Activity: Growth Factors, Insulin
					- Anti-growth factor
					- Targeted Therapy for Cancer e.g. HER2, VEGF receptor
				- Bind to Tyrosine Kinase Enzyme: Cytokines
			- GC-linked (Guanylate cyclase-linked receptor)
				- Peptide Hormone (Hydrophilic)
					- Increased cGMP
					- Atrial Natriuretic Peptide / Atrial Natriuretic Factor
	- Intracellular
		- Nuclear Receptor
			- Steroid Hormones (Lipophilic)
				- Mineralocorticoids: Aldosterone
				- Glucocorticoids: Cortisol
				- Sex Hormones: Estrogen, Progesterone, Testosterone
			- Lipophilic Molecules
				- Thyroid Hormones
				- Retinoic acid
				- Vitamin D
		- Ligand-gated ion channel on Organelle
			- Receptor for Secondary Messenger
				- IP<sub>3</sub> receptor
				- Ryanodine Receptor (RYR)
- Ligands
	- Neurotransmitter
		- Anti-Calcitonin gene-related peptide: Anti-Migraine
	- Cytokines
		- Anti-Interleukin-1: Treat Rheumatoid Arthritis
	- Growth factors, Insulin
		- Anti-Vascular Endothelial Growth Factor: Targeted Therapy for Cancer (Angiogenesis)
- Proteins
	- Voltage-gated ion channel
		- Sodium Channel Blocker: Anti-Epilepsy, Local anesthetic, Anti-Arrhythmia
		- L-type Calcium Channel Blocker: Anti-Hypertension
	- Transporter
		- Serotonin Transporter Inhibitor: Anti-depression
		- Sodium-dependent Glucose Cotransporter 2 Inhibitor: Anti-diabetes
		- Solute Carrier superfamily (SLC1 - SLC25): Organic ion transporter
		- P-glycoprotein
			- Blood brain barrier: Pump diffused xenobiotics out of the brain
			- Multidrug resistance transporter (MDR): Pump drug out of bacterial cell
				- Non-sedative antihistamines
	- Enzyme
		- Cyclooxygenase: Synthesis of Prostaglandins (Fever, Pain, Inflammation)
			- Inhibitor: Antipyretic, Analgesic, Anti-inflammation ← Ibuprofen
		- Phosphodiesterase (PDE): Destroy cAMP, cGMP
			- PDE5 inhibitor: Sildenafil: Vasodilation
		- Angiotensin converting enzyme (ACE): Inhibit Angiotensin II Synthesis
			- Vasoconstrictor, Trigger salt & water retention
			- ACE Inhibitor: Antihypertensive drug
			- Alternatively, Angiotensin II Receptor Blocker (ARB)
		- Cyclin-dependent kinase (CDK): Cell cycle
			- CDK inhibitor (CKI): Cell cycle arrest: Anti-cancer
	- Cell Adhesion Protein
		- Integrin: Leukocyte extravasation, Cancer metastasis
			- Anti-integrin: Prevent WBC Recruitment: Treat autoimmune
			- Treatment of metastatic / Recurrent Cancer
- Nucleotides
	- DNA
		- DNA synthesis Inhibition (enzymes inhibition): Anticancer, Antibiotics
		- DNA cross-linking: Anti-cancer
		- DNA strand break: Anti-cancer
	- RNA
		- Protein synthesis Inhibition: Antibiotics
- Cell Components
	- Cell Wall
		- Penicillin: Peptidoglycan synthesis
	- Cell Membrane
		- Fungal ergosterol
	- Lysosome
		- Increase lysosomal pH → Impaired autophagy
			- Chloroquine, Hydroxychloroquine: Anti-inflammatory
	- Proteasome
		- Inhibit: Anti-cancer
	- Cytoskeleton
		- Inhibit / Promote microtubule polymerization: Anti-cancer
- Cluster of Differentiation / Designation / Determinant (CD)
	- Ligands / Receptors: Immunophenotyping via cell surface molecules
	- Target of immunotherapy: Programmed Death-1 (PD-1)
- Drug action
	- Direct-acting: Activate / Inhibit receptor
	- Indirect-acting: Not through receptor
		- Increase / Decrease Ligand ← Synthesis / Degradation Enzyme
		- Inhibiting the degradation of signaling molecules
		- Inhibiting the transporters

## Non-specific Drug Target

- Physical Properties
	- Adsorption
		- Activated charcoal: Anti-diarrhea, Detoxification (ingested toxin)
	- Osmolarity
		- Mannitol: Osmotic diuretic
	- Increase Bulk
		- Psyllium: Bulk-forming Laxative
	- Increase Moisture, Reduce Surface Tension
		- Stool softener laxative
- Chemical Properties
	- Protein Denaturation, Membrane Lysis
		- Disinfectant
	- Chemical Reaction, Neutralization
		- Antacid: Peptic Ulcer, Gastroesophageal Reflux Disease
			- $\ce{Al(OH)3}$; Weak alkali; Acid neutralization
	- Chelation
		- Iron chelator
		- Chelating agent: Antidote of heavy metal
	- Ion pairs
		- Protamine sulfate (Positively charged): Heparin antidote
			- Heparin: Anticoagulant (Negatively charged)

## Reference

- Handout RAID135
